MIB joins the France Biotech network
Marseille, 9 october 2026 – Aix-Marseille Université, the coordinating institution of the Marseille Immunology Biocluster (MIB) consortium, has joined France Biotech. This membership will enable MIB to take part in national discussions on the development of companies innovating in healthcare and strengthen its links with organisations across the sector.
An independent association, France Biotech brings together entrepreneurs working in healthcare innovation and their expert partners across France. Its network provides a forum for collaboration and discussion on the challenges facing HealthTech companies.
Contributing to discussions on business development
This membership will enable MIB teams to contribute to the network’s work on topics such as financing, clinical development and industrialisation. It will also provide opportunities to engage with biotech companies, investors and business support organisations to better understand companies’ needs at different stages of their development.
Better connecting biocluster resources with business needs
For MIB, participation in France Biotech complements its existing work with immunology companies and organisations across its ecosystem. Discussions within the France Biotech network are expected to help better align the biocluster’s scientific and clinical resources with the needs of companies.
Partager
Actualités